NCT00652821View on ClinicalTrials.gov

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

Tramadol/ APAP

Tablets 37.5mg /325mg

DRUG

Ultracet

Tablets, 37.5mg/325mg

Sponsors

Collaborators (1)

AAI Clinic
All Listed Sponsors
collaborator

AAI Clinic

OTHER

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00652821 - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter